To determine the structural protein of the porcine reproductive and respiratory syndrome virus (PRRSV) involved in the production of neutralizing antibodies following clinical infection, correlation was studied between virus neutralization capability of convalescent pig sera and antibody response to the open reading frames (ORFs) 3-, 4-, 5-, and 7-encoded proteins GP 3 , GP 4 , GP 5 , and N, respectively. Individual virus genes were cloned into the pGEX-4T-1 vector, and the recombinant viral proteins were expressed in Escherichia coli fused to the glutathione S-transferase (GST) protein. The resulting GST-ORF3, GST-ORF4, GST-ORF5, and GST-ORF7 recombinant fusion proteins were purified by electroelution and used as antigens for serologic testing by indirect enzyme-linked immunosorbent assay and western immunoblotting. The overall antibody (IgG and IgM) titers to PRRSV of pooled convalescent pig sera were first determined by indirect immunofluorescence, and then sera with specific IgG titers Ͼ1:1,024 were tested for their specific virus neutralization activity and reactivity to individual recombinant fusion proteins. Except for the early immune response (as revealed by the presence of specific IgM), neutralizing titers were correlated with anti-GP 5 titers but not with anti-GP 3 and anti-GP 4 titers. The correlation between virus neutralization and anti-GP 5 titers was significant (r ϭ 0.811, P Յ 0.001).
Porcine reproductive and respiratory syndrome virus (PRRSV) is an economically important pig pathogen structurally and genomically related to the equine arteritis virus (EAV), the murine lactate dehydrogenase-elevating virus, and the simian hemorrhagic fever virus. 20, 28 These viruses have been recently classified in the genus Arterivirus, family Arteriviridae in the order Nidovirales, which also comprises members of the family Coronaviridae. 3 The genome of the PRRSV is a positive single-stranded polyadenylated RNA molecule approximately 15 kb in length containing 8 open reading frames (ORFs), which are transcribed in the infected cells as a nested set of subgenomic m-RNAs. 8, 20 The enveloped viral particles contain 3 major structural proteins, a glycosylated envelope protein of 25 kD (GP 5 ), an unglycosylated membrane (M) protein of 19 kD, and a nucleocapsid (N) protein of 14 kD, encoded by ORFs 5, 6, and 7, respectively. 16, 17, 21 The ORFs 2, 3, and 4 of the Lelystad virus, the European prototype of PRRSV, encode for putative membrane-associated glycoproteins, GP 2 , GP 3 , and GP 4 , respectively, with respective molecular masses of 30, 45, and 31 kD. 21 Kinetics of development of antiviral and neutralizing antibodies to PRRSV following clinical infection in pigs have been previously studied. 15, 24 The deter-mination of the protein(s) responsible for the induction of neutralizing antibodies is a key element to consider for the development of an efficient recombinant vaccine. Several reports clearly established that the ectodomain of the G L glycoprotein of EAV, the counterpart of the GP 5 of PRRSV, contains immunodominant epitopes that trigger the immune system to produce neutralizing and protecting antibodies in horses. 1, 4 Accordingly, monoclonal antibodies (MAbs) directed against linear nonglycosylated antigenic determinants of the major GP 5 envelope glycoprotein of PRRSV can neutralize viral infectivity in vitro. 26 Other investigators recently reported the production of neutralizing MAbs directed to the GP 4 of the Lelystad virus. 22, 33 Recombinant baculoviruses expressing the ORF 3 and ORF 5 products of a Spanish strain of PRRSV apparently also conferred partial protection against reproductive problems in pregnant sows. 29 The purpose of the present study was to further investigate the viral protein(s) associated with virus neutralization in the course of a natural PRRSV infection in pigs. A panel of pooled sera obtained from different pig farms in Quebec was screened by enzyme-linked immunosorbent assay (ELISA) and western immunoblotting using recombinant Escherichia coli-expressed glutathione S-transferase (GST) fusion proteins. A correlation between virus neutralization titers of convalescent sera and the presence of anti-GP 5 antibodies was demonstrated, but such correlation was not found in the cases of anti-GP 3 , anti-GP 4 , and anti-N specific antibodies. * Nucleotide location on the PRRSV genome was given in reference to the sequences of the prototype North American strains ATCC VR-2385 (EMBL/GenBank accession numbers U20788 and U03040) and ATCC VR-2332 (EMBL//GenBank accession number U00153). 18, 19, 23 † Sizes of individual viral genes refer to those deduced from the nucleotide sequences of the tissue culture-adapted Quebec IAF-Klop strain of PRRSV. 17
Materials and methods
Virus and extraction of genomic RNA. The Quebec reference cytopathogenic strain IAF-Klop of PRRSV 15 was plaque purified twice and propagated in MARC-145 cells, a a clone of MA-104 cells highly permissive to PRRSV. 12 The virus strain yielded titers of 10 5.4 -10 6.5 TCID 50 /ml after 5-10 successive passages in MARC-145 cells. Genomic RNA was extracted from concentrated extracellular virions by the 1step guanidium isothiocyanate-acid phenol method. 6 Cloning and sequencing of individual virus genes. Individual virus genes (ORFs 3-7) were amplified by reverse transcription-polymerase chain reaction (RT-PCR), as previously described. 17 Sequences of the oligonucleotide primers used for RT-PCR and their location on the virus genome are described in Table 1 . These primers, containing 2 restriction sites for EcoRI (sense primers) and BamHI (antisense primers) at their 5Ј end for directional cloning, were designed according to the sequence of the IAF-Klop strain of PRRSV (EMBL/GenBank accession number AF003344 for ORF 3, AF003345 for ORF 4, and U64928 for ORF 5-7 genes). 17 The PCR amplified products were purified using a DNA extraction kit, b digested with EcoRI and BamHI, and ligated into similarly treated pUC-19 c or pZero d plasmid vectors, according to the manufacturer's directions. Sequence analysis of these recombinant plasmids demonstrated that no alteration or mutation had occurred as a result of PCR amplification.
Procaryotic expression and purification of recombinant fusion proteins. ORFs 3-5 were choosen as potentially interesting genes for virus neutralization, and ORF 7 was added as a control for the ELISAs. Individual virus genes corresponding to ORFs 3, 4, 5, and 7 were cloned into the procaryotic expression vector pGEX-4T-1. c To produce GST-ORF3, GST-ORF4, GST-ORF5, and GST-ORF7 recombinant fusion proteins, competent E. coli strain BL21 (DE3) c was transformed by the respective recombinant plasmid using standard methods 32 and plated on 2YT agar medium containing 2% D-glucose and 100 g/ml of carbenicil-lin. f To prepare stocks of recombinant fusion proteins, overnight cultures of the transformed bacteria were diluted 1:100 in 2YT medium and grown at 37 C to optical density of 1.0 at 600 nm. Protein expression was then induced by addition of 0.1 mM isopropylthiogalactoside (IPTG) to the culture medium. After 4 hr incubation at 37 C under vigorous agitation (300 rpm), cells were pelleted by centrifugation and resuspended in 1:25 of the initial culture volume of ice-cold phosphate-buffered saline (PBS) containing 1 mg/ml lysozyme and 1 mM phenyl methyl sulfonyl fluoride (PMSF). g Following addition of Laemmli disruption buffer 4ϫ and boiling for 5 min, samples of the disrupted cell suspensions were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using 12% polyacrylamide slabs gels, as described previously. 17 The bands corresponding to the GST-ORF3, GST-ORF4, and GST-ORF7 fusion proteins were then electroeluted from the gel at 60 V for 6 hr in electrophoresis buffer (25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.3) and then for 1 hr in the same buffer without SDS, using an electroeluter. h The production of GST-ORF5 recombinant fusion protein was accomplished with the following modifications. After induction and incubation at 37 C, cells were pelleted and resuspended in 1:25 of the initial culture volume in ice-cold PBS containing PMSF, to which Triton X-100 was added at a final concentration of 1% after a 20-min incubation at 0 C. Cells were disrupted by sonication after another 10 min incubation on ice, and the fusion protein entirely in the form of inclusion bodies was washed twice with 0.5 M glycine-NaOH buffer, pH 9.2. The final pellet was solubilized in the same buffer containing 8 M urea. The solubilized GST-ORF5 recombinant fusion protein was refolded by chromatography on a G25 sepharose column c and subsequently purified by affinity chromatography on glutathione-sepharose 4B c and eluted with reduced glutathione (20 mM glutathione, 150 mM Tris-HCl, pH 9.6). Protein concentrations in antigen preparations were determined by protein dying and spectrophotometry. 2 Indirect ELISA. Individual PRRSV recombinant fusion proteins were used as antigens. Flat-bottom polystyrene microtitration plates were used as solid-phase adsorbents. i Optimum concentrations of recombinant fusion proteins were determined by checkerboard titration, using monospecific porcine or rabbit hyperimmune sera obtained from a previous study for ORFS 5 and 7, 16 and corresponded to a range of 0.1-0.5 g of protein per well. Recombinant fusion proteins were diluted to the appropriate concentration in 100 mM sodium carbonate-bicarbonate buffer, pH 9.6. A total reaction volume of 100 l was added in all microtitration wells. After incubation for 18 hr at 4 C, antigen-coated plates were washed 3 times with PBS containing 0.05% Tween 20 (PBS-T) and saturated for 1 hr at 25 C with PBS containing 3% skim milk powder (PBS-3). Convalescent pig sera diluted in PBS-3 were then incubated in the antigencoated wells at 25 C for 2 hr. After washing with PBS-T, goat anti-porcine IgG horseradish peroxidase conjugate f was added at a final dilution of 1:1,000 in PBS-3, and the microtiters plates were further incubated for 1 hr at 37 C. Following another washing step, the enzyme substrate solution, containing 0.08% of 3Ј,3Ј,5Ј,5Јtetramethylbenzidine f in 120 mM citrate buffer and 0.005% hydrogen peroxide (pH 5.0), was added. The reaction was stopped after 10 min at room temperature by the addition of 50 l of 2 N H 2 SO 4 to each well, and absorbance values were read at 450 nm with a spectrophotometer. j End point titers were determined from the point at which the antibody-binding curve crossed the average adsorbance attributed to nonspecific binding of the conjugated antibody for each plate.
Western immunoblotting and other serologic tests. Recombinant fusion proteins separated by SDS-PAGE were electrophoretically transferred onto nitrocellulose membranes (0.45-m pore size), k as previously described. 15 After saturation with Tris-buffered saline (TBS; 20 mM Tris, pH 8.0, 150 mM NaCl) containing 3% skim milk (TBS-3), blots were cut into strips that were incubated for 2 hr at room temperature in the presence of a 1:50 dilution of tested porcine sera in TBS-3. After 5 washes in TBS containing 0.05% Tween-20 (TBS-T), the membranes were incubated for 1 hr at 37 C in the presence of a 1:2,000 dilution of an alkaline phosphatase-conjugated goat anti-porcine IgG f in TBS-3. After 3 washes in TBS-T and 2 washes in TBS, the immune reaction was revealed by incubating the strips in the enzyme substrate solution containing 0.033% nitroblue tetrazolium and 0.017% 5-bromo-4-chloro-3-indolyl phosphate in the alkaline phosphatase buffer (100 mM Tris, pH 9.5, 100 mM NaCl, 5 mM MgCl 2 ). The reaction was stopped after 10-20 min at room temperature by washing the strips with distilled water.
The indirect immunofluorescence (IIF) test, using acetone fixed PRRSV-infected MARC-145 cells, and the virus neutralization (VN) test were performed as previously described. 15, 34 The IIF antibody titers were expressed as the reciprocal of the highest dilution of tested pig sera giving specific cytoplasmic fluorescence. The VN titers were expressed as the reciprocal of the highest serum dilution that neutralized cytopathic changes induced in MARC-145 cell monolayers by a constant dose of 100 TCID 50 of virus.
Results
The oligonucleotide primers that were selected for RT-PCR permitted the amplification of genomic fragments having the sizes predicted from the nucleotide sequence of the 3Ј end of the PRRSV genome ( Fig. 1 ; Table 1 ). These amplified genomic fragments, containing the first ATG codon of the respective structural genes, were cloned in the pGEX-4T-1 procaryotic expression vector. Following incubation in the presence of IPTG, transformed E. coli cells expressed recombinant fusion proteins, essentially in the form of inclusion bodies. The molecular masses of recombinant fusion proteins analyzed by SDS-PAGE were estimated to be 52.3 kD for GST-ORF3, 43.4 kD for GST-ORF4, 45 kD for GST-ORF5, and 39.6 kD for GST-ORF7, in accordance with the values determined previously from the amino acid sequences of the putative structural proteins of the IAF-Klop strain of PRRSV. 17 Serologic identification of the expressed recombinant fusion proteins was confirmed by western immunoblotting using the homologous porcine anti-PRRSV serum obtained from experimentally infected pigs (Fig. 2) . None of the porcine sera tested (specificpathogen-free pigs and PRRSV-infected pigs) showed reactivity towards the unfused GST (26 kD) protein (data not shown).
Serum samples obtained from Quebec pig farms that have experienced outbreaks of reproductive and respiratory problems were screened by IIF for the presence of anti-PRRSV specific IgG and IgM antibodies. Nineteen pooled sera showing high specific IgG titers (Ͼ1: 1,024) to PRRSV were selected and further tested for the presence of PRRSV neutralizing antibodies and for their reactivity by ELISA and western blotting towards GST-ORF3, GST-ORF4, GST-ORF5, and GST-ORF7 recombinant fusion proteins ( Table 2 ). None of the 3 negative pooled porcine sera tested (2609, 2620, 2621) showed reactivity to the recombinant fusion proteins. Alternatively, all of the 19 PRRSV-positive sera tested had antibodies against the GP 5 and N proteins of PRRSV, whereas the presence of antibodies against the GP 3 and the GP 4 proteins was not constant. A total of 52.6% (10/19) and 47.4% (9/19 ) of the pooled sera tested failed to react by western blotting to GST-ORF3 and GST-ORF4 recombinant fusion proteins, respectively. Comparable reactivity profiles to recombinant fusion proteins were obtained by ELISA. Nine of the pooled sera tested had specific anti-PRRSV IgM titers Ͼ1:16, as detected by IIF. These sera were thus considered to correspond to cases of early PRRSV infections and were subsequently discarded from the correlation analysis. Previous studies have demonstrated that VN antibodies to PRRSV are usually not detected until the third or fourth week postinfection, whereas IgM antibodies usually decline rapidly after the third week postinfection. 15, 24 To depict the correlation between anti-GP 5 and VN titers, mean log 10 of VN titers were plotted as a function of log 10 anti-GP 5 titers in ELISA. An apparently meaningful correlation was established (Fig. 3) . Regression analysis performed with the set of pooled pig sera, for which the IgM PRRSV-antibody titers in IIF was Ͻ1:16 (Table  2) , provided the following result: R ϭ 0.811, and for an analysis of variance (ANOVA) with VN as the dependent variable, F ϭ 21.11 and P ϭ 0.001, values that show the high significance of the correlation between both sets of data. When similar analyses were carried out with the results obtained with GP 3 and GP 4 , R values between ELISA and VN titers of 0.56 and 0.69 were obtained, with F ϭ 5.3 and 9.5 and P ϭ 0.05 and 0.01. A significant correlation (R ϭ 0.79) was obtained between the strength of the N antibody response by ELISA and the presence of neutralizing activity of the pooled sera. However in the latter case, in the ANOVA with VN as the dependent variable, F ϭ 10.4 and P ϭ 0.01.
Discussion
The use of viral recombinant proteins expressed in E. coli has been previously reported for differential diagnosis between vaccinated and infected animals or to design type-specific serologic assays. 9, 14 The pGEX-4T expression system has been used by several investigators to develop ELISAs for the detection of antibodies targeted against viral proteins carrying major antigenic determinants. 5, 7, 9, 30 In the present study, several porcine sera were screened for the presence of antibodies against ORFs 3, 4, 5, and 7 products of PRRSV. The purposes of the study were 1) to determine the antigenicity of those proteins (especially for ORFs 3 and 4) and 2) to confirm that antibodies to the GP 5 are indeed responsible for VN in natural PRRSV infection.
All pools of convalescent pig sera had reacted by western blotting towards the ORF-6-encoded viral matrix protein (data not shown). However, this ORF was not included in this study since it has already been shown that viral matrix protein is not involved in virus neutralization. 10 The present results clearly indicated that all pools of sera tested reacted against the GP 5 and N proteins of PRRSV. However, not all sera reacted to the GP 3 and GP 4 proteins. This result can be explained by poor antigenicity or by a difference in the kinetics of expression of those proteins during the viral cycle. GP 3 and GP 4 are present only at low quantities on the viral particles, 33 and therefore antibodies to these 2 viral glycoproteins probably are not abundantly produced in the course of a clinical infection. However, the possibility that epitopes may not be correctly expressed in the procaryotic system, which does not allow glycosylation and may not respect the conformation of the native viral proteins, cannot be ruled out. GP 5 was the first candidate for VN for 2 reasons. First, several investigators have already demonstrated that antigenic determinants of the major envelope glycoprotein G L of equine arteritis virus, the prototype virus of the Arterivirus genus, are involved in VN and protection. 1, 4, 5 Second, MAbs to the GP 5 of PRRSV, the counterpart of the EAV G L envelope glycoprotein, have been found to neutralize viral infectivity in vitro. 26 Accordingly, the data obtained in the present study showed the existence of a significant correlation between the presence in pig sera of neutralizing antibodies to PRRSV and their reactivity towards the ORF-5-encoded protein. The correlation obtained was comparable to that previously reported in the case of EAV. 5 However, the relatively high binding titers and low levels of neutralization suggest that most epitopes are not involved in neutralization. Moreover, neutralizing MAbs raised against the recombinant GST-ORF5 fusion protein of the IAF-Klop strain of PRRSV show different reactivity profiles to North American field isolates, 27 and consequently testing the neutralizing activity of convalescent pig sera towards the GP 5 of an heterologous strain may result in lower titers.
However, R values of lower significance were obtained between VN antibody titers and ELISA titers to either the GP 3 or the GP 4 , in contradiction with previous findings on the existence of a neutralization domain in the GP 4 of the Lelystad virus, which however was found to induce only low levels of antibodies in natural infection. 22, 33 Thus, although the GP 4 may bear neutralizing epitopes, the major neutralizing domains of PRRSV probably are associated with the GP 5 . Because a low level of amino acid sequence identity exists between the structural proteins of European and North American isolates of PRRSV, 17, 19, 23 it remains to be demonstrated if such antigenic determinants associated with VN also exist on the ORF 4 product of North American strains. The level of amino acid identity of the GP 4 of strains from both continents is only 64%. 13 Therefore the role of the GP 4 and that of the GP 3 from the North American isolates in VN and protection against PRRSV infection still remains to be established.
The higher R values determined between ELISA antibody titers to the N protein and the presence of neutralizing activity of the pooled sera is questionable, because it has been previously demonstrated that MAbs directed towards epitopes of the N protein are nonneutralizing antibodies. 10, 25 However, the N protein is the more abundant structural protein of the virion and is highly immunogenic. 11, 31 Serum antibodies against the N protein appear as early as 11 days postinfection and thereafter are detectable for approximately 6 months, as shown by IIF, western blotting, and ELISA. 10, 11, 24 Study of the kinetics of the humoral immune response to PRRSV have already shown that neutralizing antibodies are usually not detected until the third or fourth week postinfection, 15, 24 when infected pigs have already developed maximal IIF antibody titers. This would explain why a correlation was obtained between the strength of the N antibody response, as determined by ELISA and western blotting, and the presence of neutralizing activity of the pooled sera.
